What is the official website of Parexel ?

The official website of Parexel is http://www.parexel.com.

What is Parexel's cybersecurity risk score?

Parexel has an AI-generated cybersecurity risk score of 795 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Parexel experienced?

According to Rankiteo, Parexel currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Parexel been affected by any supply chain cyber incidents ?

According to Rankiteo, Parexel has been affected by a supply chain cyber incident involving Oracle, with the incident ID ORAPAR1766015901.

Does Parexel have SOC 2 Type 1 certification ?

According to Rankiteo, Parexel is not certified under SOC 2 Type 1.

Does Parexel have SOC 2 Type 2 certification ?

According to Rankiteo, Parexel does not hold a SOC 2 Type 2 certification.

Does Parexel comply with GDPR ?

According to Rankiteo, Parexel is not listed as GDPR compliant.

Does Parexel have PCI DSS certification ?

According to Rankiteo, Parexel does not currently maintain PCI DSS compliance.

Does Parexel comply with HIPAA ?

According to Rankiteo, Parexel is not compliant with HIPAA regulations.

Does Parexel have ISO 27001 certification ?

According to Rankiteo,Parexel is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Parexel operate in ?

Parexel operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Parexel have ?

Parexel employs approximately 20,434 people worldwide.

Does Parexel own any subsidiaries ?

Parexel presently has no subsidiaries across any sectors.

How many LinkedIn followers does Parexel have ?

Parexel's official LinkedIn profile has approximately 831,540 followers.

What is the NAICS classification code for Parexel ?

Parexel is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Parexel have a Crunchbase profile ?

No, Parexel does not have a profile on Crunchbase.

Does Parexel have a LinkedIn profile ?

Yes, Parexel maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/parexel.

How many cybersecurity incidents has Parexel experienced ?

As of September 25, 2026, Rankiteo reports that Parexel has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Parexel have ?

Parexel has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has Parexel faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Parexel

Boost Score +25 with badge (5 left)

795

/1000

Fair

820

/1000

Good

Parexel Vendor Cyber Rating & Cyber Score

parexel.com

Add Your Compliance Badge

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical

Parexel

Parexel CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Parexel

Vulnerability

10/2025

Oracle

ORAPAR176601590...

Loading…

A.I.

Parexel Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Parexel

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Parexel in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Parexel in 2026.

Incident Types Parexel vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Parexel in 2026.

Incident History - Parexel (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Parexel Subsidiaries

Parent Company

Parexel

Pharmaceutical Manufacturing

Website: http://www.parexel.com

Company Size: 10,000+ employees

No subsidiary data available for this company.

Loading…

Parexel Similar Companies

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Loading…

NEWS

Parexel CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

June 13, 2025 07:00 AM

Here are the winners of YourStory GCC Summit 2025 Awards

YourStory GCC Summit 2025 recognised GCCs and individuals who made outstanding contributions to putting the Indian tech landscape on the...

Read Article

December 18, 2024 08:00 AM

Exabeam Appoints Mike Byron as Chief Financial Officer

Exabeam, a global cybersecurity leader that delivers AI-driven security operations, today announced the appointment of Mike Byron as Chief Financial Officer (...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93291

SUMMARY

Omni C20 lacks proper certificate validation which could allow an attacker to perform a man-in-the-middle attack which could allow them to execute arbitrary code.

Published

Date2026-09-24

Updated

Date2026-09-24

RISK INFORMATION (Score: 9.4)

cvss3

Base Score: 9.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:L

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.5

Exploitability

3.9

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-267-02

CVE-2026-93290

SUMMARY

Omni C20 uses hard-coded credentials that could allow an attacker to monitor log files to obtain credentials to access information like mapping data.

Published

Date2026-09-24

Updated

Date2026-09-24

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 6.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-267-02

CVE-2026-93289

SUMMARY

The affected products are vulnerable to command injection attack that could allow an unauthenticated attacker to execute system commands during the pairing process.

Published

Date2026-09-24

Updated

Date2026-09-24

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: HIGH

CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.0

Complexity: HIGH

CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.6

REFERENCES

https://www.cisa.gov/news-events/ics-advisories/icsa-26-267-02

CVE-2026-88956

SUMMARY

The Botslab G980H dash camera firmware contains an authentication vulnerability in the root account exposed through the device's UART interface. The affected account does not require a password before granting access to a privileged system interface, and the interface also displays the device's WiFi password during startup. An unauthenticated attacker with physical access to the device could connect to the UART interface, obtain root privileges, and recover the WiFi password.

Published

Date2026-09-24

Updated

Date2026-09-24

RISK INFORMATION (Score: 6.8)

cvss3

Base Score: 6.8

Complexity: LOW

CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:P/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

0.9

REFERENCES

CVE-2026-88761

SUMMARY

The Botslab G980H dash camera firmware generates the default WiFi password using predictable device information, portions of which are advertised by the product. An unauthenticated attacker within WiFi range could potentially determine the remaining password characters through limited guessing and gain unauthorized access to the device network.

Published

Date2026-09-24

Updated

Date2026-09-24

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: HIGH

CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 6.0

Complexity: LOW

CVSS:4.0/AV:A/AC:L/AT:P/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.6

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Parexel Vendor Cyber Rating & Cyber Score

Parexel A.I CyberSecurity Scoring

Parexel CyberSecurity News & History

Parexel Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Parexel

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Parexel vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Parexel (X = Date, Y = Severity)

Parexel Subsidiaries

Parent Company

Parexel

Parexel Similar Companies

Torrent Pharmaceuticals Ltd

Lonza

Sanofi

Johnson & Johnson Innovative Medicine

Lupin

SUN PHARMA

MACLEODS PHARMACEUTICALS LTD.

AUROBINDO PHARMA LTD

Grifols

Parexel CyberSecurity News

Here are the winners of YourStory GCC Summit 2025 Awards

Exabeam Appoints Mike Byron as Chief Financial Officer

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Parexel CyberSecurity News & History

Parexel Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Parexel

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Parexel vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Parexel (X = Date, Y = Severity)

Parexel Subsidiaries

Parent Company

Parexel

Parexel Similar Companies

Torrent Pharmaceuticals Ltd

Lonza

Sanofi

Johnson & Johnson Innovative Medicine

Lupin

SUN PHARMA

MACLEODS PHARMACEUTICALS LTD.

AUROBINDO PHARMA LTD

Grifols

Parexel CyberSecurity News

Here are the winners of YourStory GCC Summit 2025 Awards

Exabeam Appoints Mike Byron as Chief Financial Officer

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo